Company · CIK 0001157601 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 SForm 4 → | Sep 11, 4:57 pm EDT | William John SiboldPresident and CEO, Director | 11,583 | $538.65 | $6,239,198 | 197,746 | −5.53% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 20, 4:20 pm EDT | Shannon T KelleyGeneral Counsel | 664 | $514.97 | $341,940 | 11,474 | −5.47% | late |
| Aug 15, 2026 AForm 4 → | Aug 18, 5:10 pm EDT | John C ReedDirector | 647 | — | — | 647 | — | |
| Jul 20, 2026 SForm 4 → | Jul 20, 9:16 pm EDT | William John SiboldPresident and CEO, Director | 2,500 | $547.30 | $1,368,253 | 209,329 | −1.18% | |
| Jul 17, 2026 MForm 4 → | Jul 20, 9:16 pm EDT | William John SiboldPresident and CEO, Director | 50,000 | — | — | 211,829 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:23 pm EDT | Rebecca TaubDirector | 454 | — | — | 452,667 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:21 pm EDT | Richard S LevyDirector | 454 | — | — | 22,469 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:19 pm EDT | Jacqualyn A FouseDirector | 454 | — | — | 1,551 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:16 pm EDT | James M DalyDirector | 454 | — | — | 3,081 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:12 pm EDT | Daniel J. BrennanDirector | 404 | — | — | 1,371 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:03 pm EDT | BAKER BROS. ADVISORS LP +5Director | 1,816 | — | — | 1,948,876 | — | |
| Nov 20, 2018 PForm 4 → | Nov 23, 8:53 pm EST | Paul A FriedmanChief Executive Officer, Director | 4,000 | $117.88 | $471,520 | 161,128 | +2.55% | plan? |
| Nov 19, 2018 PForm 4 → | Nov 19, 6:26 pm EST | Paul A FriedmanChief Executive Officer, Director | 4,000 | $124.00 | $496,000 | 157,128 | +2.61% | plan? |
| Nov 19, 2018 PForm 4 → | Nov 19, 6:09 pm EST | Fred B CravesDirector, 10% Owner | 2,000 | $124.69 | $249,387 | 298,067 | +0.68% | plan? |
| Nov 14, 2018 MForm 4 → | Nov 14, 6:43 pm EST | David V MilliganDirector | 10,000 | $16.46 | $164,600 | 30,000 | — | plan? |
| Sep 18, 2018 MForm 4 → | Sep 19, 4:25 pm EDT | David V MilliganDirector | 20,000 | $9.45 | $189,000 | 20,000 | — | plan? |
| Jun 11, 2018 SForm 4 → | Jun 13, 3:53 pm EDT | Marc R SchneebaumChief Financial Officer | 10,099 | $287.46 | $2,903,059 | 41,668 | −19.5% | plan? |
| Jun 11, 2018 MForm 4 → | Jun 13, 3:53 pm EDT | Marc R SchneebaumChief Financial Officer | 7,957 | $86.64 | $689,409 | 51,767 | — | plan? |
| Jun 11, 2018 SForm 4 → | Jun 12, 9:02 pm EDT | Fred B CravesDirector, 10% Owner | 5,908 | $287.46 | $1,698,314 | 113,472 | — | plan? |
| Jun 11, 2018 SForm 4 → | Jun 12, 9:02 pm EDT | Fred B CravesDirector, 10% Owner | 274,092 | $287.46 | $78,790,486 | 5,264,382 | −4.95% | plan? |
| Jun 11, 2018 SForm 4 → | Jun 12, 8:56 pm EDT | Paul A FriedmanChief Executive Officer, Director | 73,526 | $287.46 | $21,135,784 | 655,540 | −10.1% | plan? |
| Jun 11, 2018 SForm 4 → | Jun 12, 8:55 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director | 73,526 | $287.46 | $21,135,784 | 655,540 | — | plan? |
| Jun 11, 2018 SForm 4 → | Jun 12, 8:50 pm EDT | BAY CITY CAPITAL LLCDirector, 10% Owner | 280,000 | $287.46 | $80,488,800 | 113,472 | −71.2% | plan? |
| Aug 23, 2017 PForm 4 → | Aug 24, 4:04 pm EDT | Richard S LevyDirector | 2,000 | $16.12 | $32,236 | 9,100 | +28.2% | plan? |
| Aug 22, 2017 PForm 4 → | Aug 23, 4:03 pm EDT | Richard S LevyDirector | 3,550 | $16.12 | $57,209 | 7,100 | +100% | plan? |
| Aug 21, 2017 PForm 4 → | Aug 22, 4:05 pm EDT | Richard S LevyDirector | 3,550 | $15.88 | $56,358 | 3,550 | — | plan? |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:10 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 30,626 | — | — | 434,758 | — | plan? |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:10 pm EDT | Paul A FriedmanChief Executive Officer, Director | 153,128 | — | — | 153,274 | — | plan? |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:09 pm EDT | Marc R SchneebaumChief Financial Officer | 24,501 | — | — | 43,809 | — | plan? |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:55 pm EDT | Fred B CravesDirector, 10% Owner | 5,953,921 | — | — | 119,380 | — | plan? |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:26 pm EDT | Marc R SchneebaumChief Financial Officer | 22,969 | — | — | 42,277 | — | plan? amended |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:26 pm EDT | Paul A FriedmanChief Executive Officer, Director | 872,769 | — | — | 729,066 | — | plan? amended |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:25 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 1,161,938 | — | — | 432,872 | — | plan? amended |
| Jul 22, 2016 AFForm 4 → | Jul 22, 5:23 pm EDT | Chen SchorFormer President and CEO, Director | 57,107 | $9.48 | $135,090 | 37,178 | — | plan? |
| Jul 22, 2016 AFForm 4 → | Jul 22, 5:22 pm EDT | Marc R SchneebaumSVP and CFO | 34,262 | $9.48 | $81,035 | 19,308 | — | plan? |
| Jul 22, 2016 AFForm 4 → | Jul 22, 5:18 pm EDT | Wendy E RiederFormer SVP, Gen. Counsel | 34,264 | $9.48 | $81,054 | 17,730 | — | plan? |
| Jan 1, 2016 AForm 4 → | Jan 5, 6:32 pm EST | Scott D MorensteinDirector | 17,857 | — | — | 17,857 | — | plan? |
| Dec 11, 2015 SForm 4 → | Dec 15, 4:34 pm EST | Keith R GollustDirector | 600,000 | $0.3462 | $207,720 | 1,539,169 | −28.0% | plan? |
| Dec 7, 2015 SForm 4 → | Dec 9, 5:00 pm EST | Keith R GollustDirector | 745,892 | $0.3823 | $285,125 | 2,139,169 | −25.9% | plan? |
| Dec 4, 2015 SForm 4 → | Dec 8, 2:09 pm EST | Bruce KovnerDirector, 10% Owner | 1,523,346 | $0.3743 | $570,155 | 340,970 | −81.7% | plan? |
| Dec 1, 2015 SForm 4 → | Dec 3, 5:49 pm EST | Bruce KovnerDirector, 10% Owner | 1,430,753 | $0.4258 | $609,169 | 892,650 | −61.6% | plan? |
| Nov 25, 2015 SForm 4 → | Nov 30, 5:23 pm EST | Bruce KovnerDirector, 10% Owner | 3,078,820 | $0.4788 | $1,474,249 | 1,410,796 | −68.6% | plan? |
| Nov 23, 2015 SForm 4 → | Nov 24, 5:27 pm EST | Bruce KovnerDirector, 10% Owner | 1,173,582 | $0.4389 | $515,106 | 2,525,789 | −31.7% | plan? |
| Nov 18, 2015 SForm 4 → | Nov 20, 5:42 pm EST | Bruce KovnerDirector, 10% Owner | 1,513,088 | $0.4852 | $734,189 | 2,950,801 | −33.9% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 19, 6:03 pm EST | Keith R GollustDirector | 100,000 | $0.414 | $41,400 | 2,885,061 | −3.35% | plan? |
| Nov 13, 2015 SForm 4 → | Nov 17, 5:08 pm EST | Bruce KovnerDirector, 10% Owner | 1,223,936 | $0.4265 | $521,987 | 1,101,107 | −52.6% | plan? |
| Nov 10, 2015 SForm 4/A → | Nov 13, 11:20 am EST | Keith R GollustDirector | 188,322 | $0.5472 | $103,050 | 2,985,061 | −5.93% | plan? |
| Nov 10, 2015 SForm 4 → | Nov 12, 6:00 pm EST | Keith R GollustDirector | 188,322 | $0.5472 | $103,050 | 2,985,061 | — | plan? amended |
| Nov 9, 2015 SForm 4 → | Nov 12, 5:19 pm EST | Bruce KovnerDirector, 10% Owner | 5,436,673 | $0.5535 | $3,009,262 | 2,325,043 | −70.0% | plan? late |
| Sep 30, 2015 JForm 4 → | Oct 2, 12:56 pm EDT | Bruce KovnerDirector, 10% Owner | 8,241,708 | — | — | 11,399,464 | — | plan? |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:38 pm EDT | Robert N WilsonDirector | 6,818 | — | — | 760,936 | — | plan? |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:36 pm EDT | Paul A FriedmanDirector | 6,817 | — | — | 6,817 | — | plan? |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:34 pm EDT | William S ReardonDirector | 7,953 | — | — | 49,392 | — | plan? |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:31 pm EDT | Keith R GollustDirector | 49,998 | — | — | 401,764 | — | plan? |
| Jun 30, 2015 AJForm 4 → | Jul 2, 1:17 pm EDT | Bruce KovnerDirector, 10% Owner | 4,590,109 | — | — | 3,092,677 | — | plan? |
| Jun 5, 2015 AForm 4 → | Jun 8, 5:06 pm EDT | Chen SchorPresident and CEO, Director | 150,000 | — | — | 300,000 | — | plan? |
| Apr 6, 2015 PForm 4 → | Apr 8, 4:21 pm EDT | Bruce KovnerDirector, 10% Owner | 6,857,143 | $1.75 | $12,000,000 | 15,278,610 | +81.4% | plan? |
| Apr 6, 2015 PForm 4 → | Apr 8, 4:18 pm EDT | Keith R GollustDirector | 350,000 | $1.75 | $612,500 | 3,173,383 | +12.4% | plan? |
| Apr 6, 2015 PForm 4 → | Apr 8, 4:16 pm EDT | Robert N WilsonDirector | 50,000 | $1.75 | $87,500 | 754,118 | +7.10% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2026 AForm 4 → | Aug 18, 5:10 pm EDT | John C ReedDirector | 1,078 | — | — | 1,078 | — | |
| Jul 17, 2026 MForm 4 → | Jul 20, 9:16 pm EDT | William John SiboldPresident and CEO, Director | 50,000 | — | — | 0 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:23 pm EDT | Rebecca TaubDirector | 766 | — | — | 766 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:21 pm EDT | Richard S LevyDirector | 766 | — | — | 766 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:19 pm EDT | Jacqualyn A FouseDirector | 766 | — | — | 766 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:16 pm EDT | James M DalyDirector | 766 | — | — | 766 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:12 pm EDT | Daniel J. BrennanDirector | 681 | — | — | 681 | — | |
| Jun 17, 2026 AForm 4 → | Jun 18, 4:03 pm EDT | BAKER BROS. ADVISORS LP +5Director | 3,064 | — | — | 1,532 | — | |
| Mar 7, 2019 AForm 4 → | Mar 11, 3:42 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director | 38,000 | — | — | 38,000 | — | |
| Mar 7, 2019 AForm 4 → | Mar 11, 3:42 pm EDT | Paul A FriedmanChief Executive Officer, Director | 50,000 | — | — | 50,000 | — | |
| Mar 7, 2019 AForm 4 → | Mar 11, 3:41 pm EDT | Marc R SchneebaumChief Financial Officer | 28,000 | — | — | 28,000 | — | |
| Nov 14, 2018 MForm 4 → | Nov 14, 6:43 pm EST | David V MilliganDirector | 10,000 | — | — | 0 | — | |
| Sep 18, 2018 MForm 4 → | Sep 19, 4:25 pm EDT | David V MilliganDirector | 20,000 | — | — | 0 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 8:52 pm EDT | Kenneth BateDirector | 10,000 | — | — | 10,000 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 7:03 pm EDT | Richard S LevyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 7:00 pm EDT | David V MilliganDirector | 10,000 | — | — | 10,000 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 7:00 pm EDT | Keith R GollustDirector | 10,000 | — | — | 10,000 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 7:00 pm EDT | Fred B CravesDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 11, 2018 MForm 4 → | Jun 13, 3:53 pm EDT | Marc R SchneebaumChief Financial Officer | 7,957 | — | — | 1,640 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 12:47 pm EST | Marc R SchneebaumChief Financial Officer | 28,000 | — | — | 28,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 12:47 pm EST | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 38,000 | — | — | 38,000 | — | |
| Mar 1, 2018 AForm 4 → | Mar 5, 12:46 pm EST | Paul A FriedmanChief Executive Officer, Director | 50,000 | — | — | 50,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 6:01 pm EDT | David V MilliganDirector | 10,000 | — | — | 10,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 6:01 pm EDT | Richard S LevyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 6:00 pm EDT | Keith R GollustDirector | 10,000 | — | — | 10,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 6:00 pm EDT | Fred B CravesDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 5:59 pm EDT | Kenneth BateDirector | 10,000 | — | — | 10,000 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:19 pm EST | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 37,300 | — | — | 37,300 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:18 pm EST | Marc R SchneebaumChief Financial Officer | 27,300 | — | — | 27,300 | — | |
| Mar 2, 2017 AForm 4 → | Mar 6, 3:18 pm EST | Paul A FriedmanChief Executive Officer, Director | 49,600 | — | — | 49,600 | — | |
| Aug 11, 2016 AForm 4 → | Nov 21, 4:40 pm EST | Richard S LevyDirector | 20,000 | — | — | 20,000 | — | late |
| Jul 22, 2016 AForm 4/A → | Nov 4, 5:17 pm EDT | David V MilliganDirector | 20,000 | — | — | 20,000 | — | |
| Jul 22, 2016 AForm 4/A → | Nov 4, 5:17 pm EDT | Fred B CravesDirector, 10% Owner | 20,000 | — | — | 20,000 | — | |
| Jul 22, 2016 AForm 4/A → | Nov 4, 5:16 pm EDT | Kenneth BateDirector | 20,000 | — | — | 20,000 | — | |
| Jul 22, 2016 AForm 4/A → | Nov 4, 5:16 pm EDT | Keith R GollustDirector | 20,000 | — | — | 20,000 | — | |
| Jul 22, 2016 AForm 4 → | Oct 24, 7:14 pm EDT | Fred B CravesDirector, 10% Owner | 20,000 | — | — | 20,000 | — | late amended |
| Jul 22, 2016 AForm 4 → | Oct 24, 7:11 pm EDT | Keith R GollustDirector | 20,000 | — | — | 20,000 | — | late amended |
| Jul 22, 2016 AForm 4 → | Oct 24, 7:09 pm EDT | Kenneth BateDirector | 20,000 | — | — | 20,000 | — | late amended |
| Jul 22, 2016 AForm 4 → | Oct 24, 7:08 pm EDT | David V MilliganDirector | 20,000 | — | — | 20,000 | — | late amended |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:10 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 153,128 | — | — | 153,128 | — | |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:10 pm EDT | Paul A FriedmanChief Executive Officer, Director | 306,256 | — | — | 306,256 | — | |
| Jul 22, 2016 AForm 4/A → | Aug 23, 3:09 pm EDT | Marc R SchneebaumChief Financial Officer | 98,002 | — | — | 98,002 | — | |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:26 pm EDT | Marc R SchneebaumChief Financial Officer | 91,876 | — | — | 91,876 | — | amended |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:26 pm EDT | Paul A FriedmanChief Executive Officer, Director | 287,115 | — | — | 287,115 | — | amended |
| Jul 22, 2016 AForm 4 → | Jul 26, 5:25 pm EDT | Rebecca TaubChief Medical Officer, EVP R&D, Director, 10% Owner | 143,557 | — | — | 143,557 | — | amended |
| Nov 3, 2015 AForm 4 → | Nov 5, 6:40 pm EST | Scott D MorensteinDirector | 40,000 | — | — | 40,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 5:34 pm EDT | Wendy E RiederSVP, Gen. Counsel | 250,000 | — | — | 250,000 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 5:33 pm EDT | Vojo VukovicSVP, Chief Medical Officer | 132,300 | — | — | 132,300 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 5:32 pm EDT | Marc R SchneebaumSVP and CFO | 153,100 | — | — | 153,100 | — | |
| Oct 2, 2015 AForm 4 → | Oct 6, 5:29 pm EDT | Chen SchorPresident and CEO, Director | 250,000 | — | — | 250,000 | — | |
| Sep 16, 2015 AForm 4 → | Sep 18, 6:37 pm EDT | Chen SchorPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:38 pm EDT | Robert N WilsonDirector | 20,000 | — | — | 20,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:36 pm EDT | Paul A FriedmanDirector | 20,000 | — | — | 20,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:34 pm EDT | William S ReardonDirector | 20,000 | — | — | 20,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:32 pm EDT | Donald W KufeDirector | 20,000 | — | — | 20,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 6, 4:31 pm EDT | Keith R GollustDirector | 35,000 | — | — | 15,000 | — | |
| Jul 1, 2015 AForm 4 → | Jul 2, 1:17 pm EDT | Bruce KovnerDirector, 10% Owner | 20,000 | — | — | 20,000 | — | |
| Jun 5, 2015 AForm 4 → | Jun 8, 5:06 pm EDT | Chen SchorPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:19 pm EST | Wendy E RiederSVP, Gen. Counsel | 100,000 | — | — | 100,000 | — | |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:15 pm EST | Arthur McMahonSVP, Human Resources | 126,768 | — | — | 126,768 | — | |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:02 pm EST | Vojo VukovicSVP, Chief Medical Officer | 173,280 | — | — | 173,280 | — | |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:00 pm EST | Anne Clem WhitakerPresident and CEO, Director | 100,000 | — | — | 100,000 | — |